Navigation Links
Adhering to Clinical Guidelines Decreases Blood Clots in the Elderly

A multifaceted intervention designed to increase adherence with clinical guidelines for preventing deep-vein blood clots may decrease the rate of such blood clots among// elderly patients, according to a report in the October 23 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

Older adults and those in the hospital are at increased risk for deep vein thrombosis (DVT), a blood clot in the thigh or leg, according to background information in the article. Medications and compression stockings have been shown to reduce or prevent DVT in some patients. “However, several studies demonstrate a gap between scientific evidence and clinical practice in various settings, including post–acute care facilities,” the authors write. “These facilities are used to ensure the transition between short hospital stays and home when patients require specialized care or rehabilitation services.”

Elodie Sellier, M.D., Joseph Fourier University, Grenoble, France, and colleagues studied 1,373 patients age 65 or older (66.9 percent women) enrolled in 33 post–acute care facilities in France. The researchers evaluated patients for DVT before and after they implemented evidence-based guidelines for physicians and nurses at the facilities regarding prevention of DVT. The guidelines recommended that health care providers give prophylactic (preventive) medications to certain patients, such as those who recently had major surgery or who previously had DVT. Physical therapy, compression stockings and other non-drug preventive measures were recommended for other patients or in addition to medications in some cases. Educational sessions were held to communicate the guidelines; physicians and nurses were given posters and plastic cards as reminders. The researchers assessed 709 patients before and 664 patients following the implementation of the guidelines.

Before the guidelines were put in place, a blood clot was found in 91 (12.8 percent) of 709 patients. Following the intervention, clots were found in only 52 (7.8 percent) of 664 patients. The post-intervention participants were more likely to use compression stockings and less likely to take medications that were not recommended by the guidelines, especially if they were patients for whom drug therapy was not recommended under the guidelines.

“Changes in the prophylaxis means measured can only partly explain the decrease in the rate of DVT observed in our study. The most important change in prophylaxis consisted of an increased use of graduated compression stockings, while the change in pharmacologic prophylaxis use was modest and not statistically significant,” the authors write.

“These observations together suggest that our multifaceted intervention not only altered the use of measured prophylaxis means but also improved physician and nurse awareness of patients at risk for venous thromboembolism and eventually increased the use of additional prophylactic measures including early ambulation and physical therapy, which were addressed by our intervention but not investigated in our study,” they continue. Additional efforts should be undertaken to ensure that physicians and nurses comply with evidence-based guidelines for the prevention of DVT, they conclude.

Source-Newswie
SRM
'"/>




Related medicine news :

1. Clinical trials need to be more frank
2. Physicians Lack Clinical Guidelines For Treating Elderly With Multiple Illnesses
3. The Growing Rise In Clinical Research Could Lead To A Compromise In Quality Of Research And Ethics
4. Clinical Comparisons Between ADHD Drugs Are Less
5. A Novel System For Clinical Banking Of Umbilical Cord Blood
6. Clinical Renal Trails Do Not Have Sufficient Women Participants
7. Clinical Trials of New Drug Febuxostat Show Promise in Gout Treatment
8. Clinical Trials Of New Anti-Cancer Drug To Be Initiated In New Zealand
9. Green Tea Consumption Found To Improve Clinical Outcome In Cancer Patients
10. Cancer Clinical Research in India
11. New Generation Clinical Trials Could Save Time And Money, Improve Patient Care
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/12/2016)... ... February 12, 2016 , ... CDRH Enforcement Trends: , Back to the Future , Feb. ... , As Winston Churchill said, “Those who don’t learn from history are doomed to repeat ... when they come knocking this year. But that takes time. , Take a close ...
(Date:2/12/2016)... ... ... Each year, the American Physical Therapy Association (APTA) offers a Combined Sections ... Center. Almost 10,000 physical therapists across the country are expected to attend this annual ... chosen field and network with their colleagues. As in years past, HydroWorx is ...
(Date:2/12/2016)... ... , ... Coco Libre, the maker of coconut water beverages with a purpose, ... Event. Coco Libre will offer musicians and celebrities the company’s signature Organic Coconut Water, ... gifting suite, held this year at the W Hollywood Hotel, has become a pre-show ...
(Date:2/12/2016)... ... February 12, 2016 , ... The ThedaCare Center for Healthcare ... Hospital on April 5-7. The series is a multi-day, multi-workshop event designed to ... cover a broad range of topics, including coaching skills, the scientific method of ...
(Date:2/12/2016)... PITTSBURGH, Pa. (PRWEB) , ... February 12, 2016 , ... ... space heaters. , This winter the West Penn Burn Center, part of ... Fire Company #1, to bring you the “Space Heaters Need Space” campaign. ...
Breaking Medicine News(10 mins):
(Date:2/11/2016)...  Kindred Biosciences, Inc. (NASDAQ: KIN ), a ... of pets, today announced the submission to FDA of ... Application (NADA) for Zimeta™ (dipyrone injection, KIND-012).  Positive topline ... for the control of pyrexia (fever) in horses were ... --> The Chemistry, Manufacturing, and Controls ...
(Date:2/11/2016)...   Health 2.0 , the premiere showcase and ... today " 10 Year Global Retrospective ", a platform ... past ten years.   --> ... has served as the preeminent thought-leader in the health ... technologies, companies, innovators, and patient-activists through an array of ...
(Date:2/11/2016)... , Feb. 11, 2016  MiMedx Group, Inc. (NASDAQ: ... human amniotic membrane and other birth tissues, human skin ... develop and market advanced products and therapies, announced today ... 2016 Global Healthcare Conference in New York ... CEO, Michael J. Senken , Chief Financial Officer ...
Breaking Medicine Technology: